Long-acting β2-agonist use in South African children : letter
To the Editor : As doctors involved in the management of children with asthma, we have noted with concern the recent debate on and adverse publicity given to the long-acting β2-agonists (LABAs) used to treat children with asthma. We feel that the issue needs clarification.
Gespeichert in:
| Veröffentlicht in: | SAJCH : the South African journal of child health 2007-01, Vol.1 (1), p.40 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | 40 |
| container_title | SAJCH : the South African journal of child health |
| container_volume | 1 |
| creator | Lewis, Humphrey Green, Robin J. Ossip, Mervyn |
| description | To the Editor : As doctors involved in the management of children with asthma, we have noted with concern the recent debate on and adverse publicity given to the long-acting β2-agonists (LABAs) used to treat children with asthma. We feel that the issue needs clarification. |
| format | Article |
| fullrecord | <record><control><sourceid>sabinet_JRA</sourceid><recordid>TN_cdi_sabinet_saepub_10520_EJC64652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sabinet_id>10520/EJC64652</sabinet_id><sourcerecordid>10520/EJC64652</sourcerecordid><originalsourceid>FETCH-sabinet_saepub_10520_EJC646523</originalsourceid><addsrcrecordid>eNpjYuA0tLS01DU3MzdkAbNNdI0NjI04GLiKi7MMDMwMTCwsOBnsfPLz0nUTk0sy89IVzm0y0k1Mz8_LLC5RKC1OVcjMUwjOLy3JUHBMK8pMTsxTSM7IzEkpSs1TsFLISS0pSS3iYWBNS8wpTuWF0twMKm6uIc4eusWJSZl5qSXxxYmpBaVJ8YYGpkYG8a5ezmYmZqZGxkQqAwDp9ziu</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Long-acting β2-agonist use in South African children : letter</title><source>Sabinet African Journals Open Access Collection</source><creator>Lewis, Humphrey ; Green, Robin J. ; Ossip, Mervyn</creator><creatorcontrib>Lewis, Humphrey ; Green, Robin J. ; Ossip, Mervyn</creatorcontrib><description>To the Editor : As doctors involved in the management of children with asthma, we have noted with concern the recent debate on and adverse publicity given to the long-acting β2-agonists (LABAs) used to treat children with asthma. We feel that the issue needs clarification.</description><identifier>ISSN: 1994-3032</identifier><identifier>EISSN: 1999-7671</identifier><language>eng</language><publisher>Health and Medical Publishing Group (HMPG)</publisher><ispartof>SAJCH : the South African journal of child health, 2007-01, Vol.1 (1), p.40</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,39219</link.rule.ids><linktorsrc>$$Uhttp://hdl.handle.net/10520/EJC64652$$EView_record_in_Sabinet_Online_Ltd.$$FView_record_in_$$GSabinet_Online_Ltd.</linktorsrc></links><search><creatorcontrib>Lewis, Humphrey</creatorcontrib><creatorcontrib>Green, Robin J.</creatorcontrib><creatorcontrib>Ossip, Mervyn</creatorcontrib><title>Long-acting β2-agonist use in South African children : letter</title><title>SAJCH : the South African journal of child health</title><description>To the Editor : As doctors involved in the management of children with asthma, we have noted with concern the recent debate on and adverse publicity given to the long-acting β2-agonists (LABAs) used to treat children with asthma. We feel that the issue needs clarification.</description><issn>1994-3032</issn><issn>1999-7671</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpjYuA0tLS01DU3MzdkAbNNdI0NjI04GLiKi7MMDMwMTCwsOBnsfPLz0nUTk0sy89IVzm0y0k1Mz8_LLC5RKC1OVcjMUwjOLy3JUHBMK8pMTsxTSM7IzEkpSs1TsFLISS0pSS3iYWBNS8wpTuWF0twMKm6uIc4eusWJSZl5qSXxxYmpBaVJ8YYGpkYG8a5ezmYmZqZGxkQqAwDp9ziu</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Lewis, Humphrey</creator><creator>Green, Robin J.</creator><creator>Ossip, Mervyn</creator><general>Health and Medical Publishing Group (HMPG)</general><scope/></search><sort><creationdate>20070101</creationdate><title>Long-acting β2-agonist use in South African children : letter</title><author>Lewis, Humphrey ; Green, Robin J. ; Ossip, Mervyn</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-sabinet_saepub_10520_EJC646523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lewis, Humphrey</creatorcontrib><creatorcontrib>Green, Robin J.</creatorcontrib><creatorcontrib>Ossip, Mervyn</creatorcontrib><jtitle>SAJCH : the South African journal of child health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lewis, Humphrey</au><au>Green, Robin J.</au><au>Ossip, Mervyn</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-acting β2-agonist use in South African children : letter</atitle><jtitle>SAJCH : the South African journal of child health</jtitle><date>2007-01-01</date><risdate>2007</risdate><volume>1</volume><issue>1</issue><spage>40</spage><pages>40-</pages><issn>1994-3032</issn><eissn>1999-7671</eissn><abstract>To the Editor : As doctors involved in the management of children with asthma, we have noted with concern the recent debate on and adverse publicity given to the long-acting β2-agonists (LABAs) used to treat children with asthma. We feel that the issue needs clarification.</abstract><pub>Health and Medical Publishing Group (HMPG)</pub></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | ISSN: 1994-3032 |
| ispartof | SAJCH : the South African journal of child health, 2007-01, Vol.1 (1), p.40 |
| issn | 1994-3032 1999-7671 |
| language | eng |
| recordid | cdi_sabinet_saepub_10520_EJC64652 |
| source | Sabinet African Journals Open Access Collection |
| title | Long-acting β2-agonist use in South African children : letter |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A58%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-sabinet_JRA&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-acting%20%CE%B22-agonist%20use%20in%20South%20African%20children%20:%20letter&rft.jtitle=SAJCH%20:%20the%20South%20African%20journal%20of%20child%20health&rft.au=Lewis,%20Humphrey&rft.date=2007-01-01&rft.volume=1&rft.issue=1&rft.spage=40&rft.pages=40-&rft.issn=1994-3032&rft.eissn=1999-7671&rft_id=info:doi/&rft_dat=%3Csabinet_JRA%3E10520/EJC64652%3C/sabinet_JRA%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_sabinet_id=10520/EJC64652&rfr_iscdi=true |